These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 20661178

  • 1. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group.
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [Abstract] [Full Text] [Related]

  • 2. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
    Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A, Costa Rican Vaccine Trial Group.
    J Natl Cancer Inst; 2010 Nov 03; 102(21):1653-62. PubMed ID: 20944077
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
    Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group.
    Sex Transm Dis; 2011 Oct 03; 38(10):976-82. PubMed ID: 21934576
    [Abstract] [Full Text] [Related]

  • 4. Determinants of seropositivity among HPV-16/18 DNA positive young women.
    Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, Herrero R, Hildesheim A, Costa Rica HPV Vaccine Trial (CVT) Group.
    BMC Infect Dis; 2010 Aug 11; 10():238. PubMed ID: 20698998
    [Abstract] [Full Text] [Related]

  • 5. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
    Fei M, Li J, Du J, You J, Zhang S, He W, Kang L, Zhao F, Qiao Y, Si Y, Fan X, Chen W.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May 11; 35(5):514-8. PubMed ID: 25059358
    [Abstract] [Full Text] [Related]

  • 6. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
    Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M.
    BMC Infect Dis; 2014 Mar 03; 14():120. PubMed ID: 24588945
    [Abstract] [Full Text] [Related]

  • 7. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.
    Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, Herrero R, Hildesheim A, Kreimer AR, Costa Rica Vaccine Trial Group.
    J Infect Dis; 2014 Dec 15; 210(12):1890-9. PubMed ID: 24958910
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
    Velentzis LS, Sitas F, O'Connell DL, Darlington-Brown J, Egger S, Sinha R, Banks E, Frazer IH, Canfell K.
    BMC Infect Dis; 2014 Dec 21; 14():3861. PubMed ID: 25528152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.
    Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, Wheeler CM, Hildesheim A, Costa Rica Vaccine Trial and PATRICIA Study.
    J Natl Cancer Inst; 2020 Aug 01; 112(8):818-828. PubMed ID: 31697384
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.
    Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, Hildesheim A, Herrero R, CVT Vaccine Group.
    Lancet Oncol; 2011 Sep 01; 12(9):862-70. PubMed ID: 21865087
    [Abstract] [Full Text] [Related]

  • 16. Sex differences in HPV immunity among adults without cancer.
    Windon MJ, Waterboer T, Hillel AT, Chien W, Best S, Stewart C, Akst L, Troy T, Bender N, Miles B, Ryan WR, Mandal R, Pitman K, Eisele DW, Fakhry C, D'Souza G.
    Hum Vaccin Immunother; 2019 Sep 01; 15(7-8):1935-1941. PubMed ID: 30650013
    [Abstract] [Full Text] [Related]

  • 17. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
    Vink MA, Berkhof J, van de Kassteele J, van Boven M, Bogaards JA.
    PLoS One; 2016 Sep 01; 11(8):e0161109. PubMed ID: 27537200
    [Abstract] [Full Text] [Related]

  • 18. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
    Simen-Kapeu A, Kataja V, Yliskoski M, Syrjänen K, Dillner J, Koskela P, Paavonen J, Lehtinen M.
    Scand J Infect Dis; 2008 Sep 01; 40(9):745-51. PubMed ID: 19086247
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, Linford C, Lowndes CM, Nardone A, Pebody R, Soldan K.
    Sex Transm Dis; 2011 Jul 01; 38(7):622-9. PubMed ID: 21317688
    [Abstract] [Full Text] [Related]

  • 20. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
    Husaiyin S, Han L, Mamat H, Husaiyin K, Wang L, Niyazi M.
    Jpn J Infect Dis; 2016 Jul 22; 69(4):273-8. PubMed ID: 26255734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.